Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

AKAR, Ebru; Oner, VEYSİ; Kucukerdonmez, Cem; AKOVA, Yonca

doi:10.3980/j.issn.2222-3959.2013.02.05

Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

Copy For Citation

AKAR E. E., Oner V., Kucukerdonmez C., AKOVA Y. A.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, vol.6, no.2, pp.136-140, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 6 Issue: 2
Publication Date: 2013
Doi Number: 10.3980/j.issn.2222-3959.2013.02.05
Journal Name: INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.136-140
Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

AIM: To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model.